EMA restricts use of MS medicine Zinbryta

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

EMA restricts use of MS medicine Zinbryta

Postby MSUK » Mon Jul 17, 2017 8:48 am

The European Medicines Agency (EMA) has provisionally restricted the use of multiple sclerosis (MS) drug Zinbryta (daclizumab) to patients with highly active relapsing remitting MS (RRMS) that has failed to respond to certain other treatment, and to patients with rapidly evolving relapsing MS who cannot be treated with other medicines...Read more - http://www.ms-uk.org/ema-restricts-use-ms-medicine-zinbryta-170717
MS-UK - http://www.ms-uk.org/
User avatar
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 3:00 pm


Return to General Discussion


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service